Intravenous thrombolysis for acute cerebral ischemia in Belgrade, Serbia: Comparison with Lille, France

European Neurology

Volumn 66, Issue 1, 2011, Pages 30-36

  Bogosavljevic, Visnja ^a,b   Bodenant, Marie ^c,d   Beslac Bumbasirevic, Ljiljana ^a,b   Cordonnier, Charlotte ^c,d   Jovanovic, Dejana R ^a,b   Budimkic, Maja ^a,b   Leys, Didier ^c,d  

^a Institute of Neurology Clinical Centre of Serbia   (Yugoslavia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIV LILLE   (France)

Author keywords

Acute cerebral ischemia; Intravenous thrombolysis outcome; Symptomatic hemorrhagic transformation

Indexed keywords

ALTEPLASE;

ADULT; AGED; ALCOHOLISM; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL ASSESSMENT; COMPARATIVE STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; SMOKING; STROKE; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SERBIA; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79959570839     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000328018     Document Type: Article

References (20)

1. Lees KR, Bluhmki E, von Kummer R, et al: Time to treatment with intravenous alteplase and outcome in stroke: An updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375: 1695-1703.
2. Wahlgren N, Ahmed N, Davalos A, et al: Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): An observational study. Lancet 2007; 369: 275-282. (Pubitemid 46138121)
3. Wahlgren N, Ahmed N, Davalos A, et al: Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): An observational study. Lancet 2008; 372: 1303-1309.
4. Pekmezovic T, Tepavcevic DK, Jarebinski M, Kostic M, Bumbasirevic L: Stroke mortality in Belgrade, Serbia: Age, period, and cohort analyses. Cerebrovasc Dis 2007; 24: 191-195. (Pubitemid 47299044)
5. United Nations: Statistics Division -Demographic and Social Statistics. http://unstats. un.org/unsd/demographic/products/socind/ inc-eco.htm.
6. Leys D, Bejot Y, Debette S, Giroud M: Burden of stroke in France. Int J Stroke 2008; 3: 117-119. (Pubitemid 351566845)
7. Bodenant M, Leys D, Debette S, et al: Intravenous thrombolysis for acute cerebral ischaemia: Comparison of outcomes between patients treated at working versus nonworking hours. Cerebrovasc Dis 2010; 30: 148-156.
8. Cordonnier C, Girot M, Dorp E, et al: Stroke units from scientific evidence to practice: The experience of the Lille stroke unit. Cerebrovasc Dis 2000; 10(suppl 4):17-20.
9. Leys D, and the members of the Lille stroke program. Misdiagnoses in 1,250 consecutive patients admitted in an acute stroke unit. Cerebrovasc Dis 1997; 7: 284-288. (Pubitemid 27444823)
10. Jovanovic DR, Beslac-Bumbasirevic L, Budimkic M, et al: Do women benefit more from systemic thrombolysis in acute ischemic stroke? A Serbian experience with thrombolysis in ischemic stroke (SETIS) study. Clin Neurol Neurosurg 2009; 111: 729-732.
11. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
12. Hacke W, Kaste M, Fieschi C, et al: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-1025.
13. Hacke W, Kaste M, Bluhmki E, et al: Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
14. Demchuk AM, Hill MD, Barber PA, et al: Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke 2005; 36: 2110-2115. (Pubitemid 41429229)
15. Adams HP Jr., Bendixen BH, Kappelle LJ, et al: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41. (Pubitemid 23014379)
16. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-607.
17. Bendel R, Afifi A: Comparison of stopping rules in forward regression. J Am Stat Assoc 1977; 72: 46-53.
18. Glantz S, Slinker B: Primer of Applied Regression and Analysis of Variance. New York, McGraw Hill, 1990.
19. Ministry of Health of Republic of Serbia: Istrazivanje zdravlja stanovnika Republike Srbije. 2006. http://www.zdravlje.gov.rs/ showpage.php?id=142.
20. Hacke W, Donnan G, Fieschi C, et al: Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-774.